Differential effect of chlorimipramine and nortriptyline on cerebrospinal fluid metabolites of serotonin and noradrenaline in depression.
D002997:Clomipramine / Q000494:pharmacology* / Q000627:therapeutic use; D003863:Depression / Q000134:cerebrospinal fluid* / Q000188:drug therapy; D003984:Dibenzazepines / Q000494:pharmacology*; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000037:antagonists & inhibitors / Q000134:cerebrospinal fluid; D008734:Methoxyhydroxyphenylglycol / Q000037:antagonists & inhibitors / Q000134:cerebrospinal fluid; D009638:Norepinephrine / Q000134:cerebrospinal fluid*; D009661:Nortriptyline / Q000494:pharmacology* / Q000627:therapeutic use; D010919:Placebos; D012701:Serotonin / Q000134:cerebrospinal fluid*
D003984:Dibenzazepines; D010919:Placebos; D012701:Serotonin; D008734:Methoxyhydroxyphenylglycol; D006897:Hydroxyindoleacetic Acid; D009661:Nortriptyline; D002997:Clomipramine; D009638:Norepinephrine